Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 88-95

  Mark, Alicja Budek ^a   Poulsen, Malene Wibe ^a   Andersen, Stine ^a   Andersen, Jeanette Marker ^a,b   Bak, Monika Judyta ^a,b   Ritz, Christian ^a   Holst, Jens Juul ^c   Nielsen, John ^b   De Courten, Barbora ^b,d,e   Dragsted, Lars Ove ^a   Bügel, Susanne Gjedsted ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Capital Region   (Denmark)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FRUCTOSE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ANTHROPOMETRY; ARTICLE; AUTOFLUORESCENCE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERVENTION STUDY; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; URINE LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; COMPARATIVE STUDY; DIET RESTRICTION; DIET THERAPY; DOUBLE BLIND PROCEDURE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; FASTING; FEMALE; FRUCTOSE; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OVERWEIGHT; YOUNG ADULT;

EID: 84892425153     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0842     Document Type: Article

References (35)

1. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: Health implications for the 21st century. Am J Clin Nutr 2005;81:341-354
2. Henle T. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids 2005;29: 313-322
3. Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010;110:911-916.e12
4. Henle T, Schwarzenbolz U, Klostermeyer H. Detection and quantification of pentosidine in foods. Z Lebensm Unters Forsch A 1997; 204:95-98
5. Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: Novel mediators of cellular dysfunction. Mol Med 2002;8:337-346
6. Vlassara H, Striker GE. AGE restriction in diabetes mellitus: A paradigm shift. Nat Rev Endocrinol 2011;7:526-539
7. Hofmann SM, Dong HJ, Li Z, et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 2002;51:2082-2089
8. Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 2005;54: 2314-2319
9. CaiW, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin. Proc Natl Acad Sci USA 2012;109: 15888-15893
10. Jia X, Wu L. Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats. Mol Cell Biochem 2007;306:133-139
11. Uribarri J, Cai W, Ramdas M, et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: Potential role of AGER1 and SIRT1. Diabetes Care 2011;34: 1610-1616
12. Birlouez-Aragon I, Saavedra G, Tessier FJ, et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 2010;91:1220-1226
13. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999;48:1-9
14. Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 1997;94:6474-6479
15. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993;58(Suppl.): 754S-765S
16. Orskov C, Jeppesen J, Madsbad S, Holst JJ. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 1991;87:415-423
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419
18. Gutt M, Davis CL, Spitzer SB, et al. Validation of the insulin sensitivity index (ISI(0,120)): Comparison with other measures. Diabetes Res Clin Pract 2000;47: 177-184
19. Bingham S, Cummings JH. The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin Sci (Lond) 1983;64:629-635
20. Jongberg S, Rasmussen M, Skibsted LH, Olsen K. Detection of advanced glycation end-products (AGEs) during dry-state storage of b-lactoglobulin/ lactose. Aust J Chem 2012;65:1620-1624
21. Radikova Z, Koska J, Huckova M, et al. Insulin sensitivity indices: A proposal of cutoff points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 2006;114:249-256
22. Uusitupa M, Hermansen K, Savolainen MJ, et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndromeda randomized study (SYSDIET). J Intern Med 2013;274:52-66
23. Livingstone MB, Black AE. Markers of the validity of reported energy intake. J Nutr 2003;133(Suppl. 3):895S-920S
24. Macdiarmid J, Blundell J. Assessing dietary intake: Who, what and why of underreporting. Nutr Res Rev 1998;11:231-253
25. Unoki H, Bujo H, Yamagishi S, Takeuchi M, Imaizumi T, Saito Y. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 2007; 76:236-244
26. Vlassara H, Cai WJ, Goodman S, et al. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: Role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab 2009;94:4483-4491
27. Harcourt BE, Sourris KC, Coughlan MT, et al. Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int 2011;80:190-198
28. Vlassara H, Cai WJ, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002;99:15596-15601
29. Uribarri J, Peppa M, Cai WJ, et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 2003;14:728-731
30. Cassese A, Esposito I, Fiory F, et al. In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 2008;283:36088-36099
31. Miele C, Riboulet A, Maitan MA, et al. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism. J BiolChem 2003;278:47376-47387
32. Ames JM. Determination of N epsilon-(carboxymethyl)lysine in foods and related systems. Ann N Y Acad Sci 2008;1126:20-24
33. Zhang G, Huang G, Xiao L, Mitchell AE. Determination of advanced glycation endproducts by LC-MS/MS in raw and roasted almonds (Prunus dulcis). J Agric Food Chem 2011;59:12037-12046
34. Delgado-Andrade C, Tessier FJ, Niquet-Leridon C, Seiquer I, Pilar Navarro M. Study of the urinary and faecal excretion of Ń-carboxymethyllysine in young human volunteers. Amino Acids 2012;43:595-602
35. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330